Finnish Institute for Health and Welfare: Hepatitis C in Finland is mainly linked to injection drug use
The Finnish Institute for Health and Welfare (THL) has released new information on the most common causes of hepatitis C infections in Finland. According to a recent report, the majority of hepatitis C cases in the country are linked to the use of intravenous drugs.
Hepatitis C is a viral liver disease that, if left untreated, can lead to serious health problems such as liver cirrhosis or liver cancer. Several hundred infections are diagnosed in Finland annually, and authorities are monitoring the situation closely to safeguard public health.
According to THL, the prevention of infections is a key part of Finnish healthcare. The most important methods for reducing infections include the availability of clean injection equipment, needle exchange services, and low-threshold health counseling. These services help reduce the spread of the virus among high-risk groups.
Treatment for the disease has advanced significantly in recent years. Current medical treatments are highly effective and can permanently cure most patients. THL emphasizes that early diagnosis and the initiation of treatment are key to ensuring that patients receive the help they need in a timely manner.
Authorities continue their work to reduce infections and increase awareness. The goal is to bring hepatitis C under control in Finland as effectively as possible in the coming years.